Focused Capital Investment in Growth and R&D Areas
First written in FY2016. 24 of 34 entries say "Restated". Latest entry: FY2026.
41 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Group made ¥22,359 million in capital expenditures, primarily in the Industrial Process and Visual Imaging businesses.」
Capital expenditures increased to ¥22,359 million, or 150.6% of the previous fiscal year's level, as targeted investment expanded, primarily in exposure equipment for semiconductor applications and advanced visual production. - FY2026-H1RestatedAnnual report
「The amount spent on research and development activities by the Group during the six months ended the interim period was ¥6,509 million. There were no material changes in the status of the Group's research and development activities during the six months ended the interim period.」
The Group continued its research and development activities, with research and development expenses for the first half amounting to ¥6,509 million. It was stated that there were no material changes in the status of those activities. - FY2025-H1AdvancedAnnual report
「The amount spent on research and development activities by the Group during the six months ended the interim period was ¥6,969 million. There were no material changes in the status of the Group's research and development activities during the six months ended the interim period.」
Research and development expenses for the first half increased to ¥6,969 million from ¥6,405 million in the same period of the previous year. It was stated that there were no material changes in the status of the research and development activities. - FY2024AdvancedAnnual report
「The Group made ¥13,223 million in capital expenditures, primarily in the Industrial Process, Visual Imaging and Photonics Solution businesses.」
Capital expenditures in growth and research and development areas increased to ¥13,223 million, or 145.2% of the previous fiscal year's level, confirming the expansion of targeted investment. - FY2024-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group during the six months ended the second quarter was ¥6,405 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」
The Group continued its research and development activities and recorded ¥6,405 million in research and development expenses for the first half. It stated that there were no material changes in the status of those activities. - FY2024-Q1RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter was ¥3,176 million. There were no material changes in the status of the Group's research and development activities during the three months ended the first quarter.」
The Group continued its research and development activities, recording ¥3,176 million for the three months ended the first quarter. It stated that there were no material changes in the status of those activities. - FY2023AdvancedAnnual report
「The Group's total research and development expenses for the fiscal year under review were ¥11,460 million, primarily related to the Light Source, Optical Equipment and Visual Imaging businesses.」
Research and development expenses increased to ¥11,460 million from ¥10,543 million in the previous year. Capital expenditures also increased to ¥9,107 million, or 123.4% of the previous fiscal year's level. - FY2023-Q3RestatedAnnual report
「The amount spent on research and development activities by the Group during the nine months ended the third quarter was ¥8,501 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」
The Group continued its research and development activities, reporting research and development expenses of ¥8,501 million for the nine months ended the third quarter, while stating that there were no material changes in the status of those activities. - FY2023-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group during the six months ended the second quarter was ¥5,799 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」
The Group continued its research and development activities, reporting research and development expenses of ¥5,799 million for the six months ended the second quarter. It stated that there were no material changes in the status of those activities. - FY2023-Q1RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter was ¥2,729 million. There were no material changes in the status of the Group's research and development activities during the three months ended the first quarter.」
The Group continued its research and development activities, reporting research and development expenses of ¥2,729 million for the first quarter, while stating that there were no material changes in the status of those activities. - FY2022AdvancedAnnual report
「The Group continued to carefully select capital-investment projects in each segment and pursue investment efficiency, while making focused investments to strengthen its competitiveness in areas expected to grow in the future. As a result, capital investment increased.」
The Group continued targeted investment in growth and research and development areas, and capital expenditures increased to ¥7,378 million, or 107.1% of the previous fiscal year's level. The Optical Equipment business was designated as a priority business, while investment in the Visual Imaging business also increased as it recovered. - FY2022-Q3RestatedAnnual report
「The amount spent on research and development activities by the Group during the nine months ended the third quarter was ¥7,690 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」
The Group continued its research and development activities, reporting research and development expenses of ¥7,690 million for the nine months ended the third quarter. It stated that there were no material changes in the status of those activities. - FY2022-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group during the six months ended the second quarter was ¥4,834 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」
The Group allocated ¥4,834 million to research and development activities in the first half and reaffirmed its policy of continuing those activities, stating that there were no material changes in their status. - FY2022-Q1RestatedAnnual report
「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter was ¥2,289 million. There were no material changes in the status of the Group's research and development activities during the three months ended the first quarter.」
The Group continued its research and development activities, reporting research and development expenses of ¥2,289 million for the quarter and no material changes in the status of those activities. - FY2021RestatedAnnual report
「The Group invested ¥6,886 million in capital expenditures, mainly in its Light Source and Optical Equipment businesses, with a focus on expanding existing facilities and on businesses and research and development areas expected to grow in the future.」
The Group maintained its policy of targeted investment in growth and research and development areas and made ¥6,886 million in capital expenditures. - FY2021-Q3RestatedAnnual report
「The amount spent on research and development activities by the Group during the nine months ended the third quarter was ¥7,337 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」
The Group continued its research and development activities, reporting ¥7,337 million for the nine months ended the third quarter. It stated that there were no material changes in the status of those activities. - FY2021-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group during the six months ended the second quarter was ¥4,947 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」
The Group continued its research and development activities, reporting research and development expenses of ¥4,947 million for the first half and no material changes in the status of those activities. - FY2020SoftenedAnnual report
「During the fiscal year under review, each segment continued to pursue capital investment focused on investment efficiency by carefully selecting projects, while making targeted investments to strengthen the Group's competitiveness in businesses expected to grow in the future. As a result, capital expenditures decreased.」
While continuing targeted investment in growth areas, the Company carefully selected investment projects, and capital expenditures decreased to ¥8,270 million, or 97.7% of the previous fiscal year's level. - FY2020-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥7.670 billion during the cumulative third-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative third-quarter period.」
The Group disclosed cumulative third-quarter R&D spending of ¥7.670 billion and stated that there were no material changes in the status of its activities. - FY2020-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥5.051 billion during the cumulative second-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative second-quarter period.」
The Group disclosed first-half R&D spending of ¥5.051 billion while continuing its R&D activities and stating that there were no material changes in the status of the activities. - FY2020-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥2.590 billion during the cumulative first-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative first-quarter period.」
The Group disclosed R&D spending of ¥2.590 billion for the quarter while continuing its R&D activities and stating that there were no material changes in the status of the activities. - FY2019AdvancedAnnual report
「The Group continued to carefully select capital-investment projects in each segment and pursue investment efficiency, while making focused investments to strengthen its competitiveness in areas expected to grow in the future. As a result, capital investment increased.」
Capital investment in growth and R&D areas continued, with capital investment totaling ¥8.462 billion, or 160.94% of the previous fiscal year's level. - FY2019-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥7.715 billion during the cumulative third-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative third-quarter period.」
The Group allocated ¥7.715 billion to R&D activities and reaffirmed its policy of continuing them, stating that there were no material changes in their status. - FY2019-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥5.136 billion during the cumulative second-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative second-quarter period.」
The Group allocated ¥5.136 billion to R&D activities and reaffirmed its policy of continuing them, stating that there were no material changes in their status. - FY2019-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥2.560 billion during the cumulative first-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative first-quarter period.」
The Group disclosed R&D spending of ¥2.560 billion for the quarter while continuing its R&D activities. No material changes in the status of the activities were reported. - FY2018SoftenedAnnual report
「The Group invested ¥5.258 billion in capital expenditures, focusing mainly on the light-source and equipment businesses, to expand existing facilities and support businesses and R&D areas expected to grow in the future. Capital investment declined during the fiscal year as each segment carefully selected investment projects in pursuit of investment efficiency.」
The focus on growth businesses and R&D areas was maintained, but investment projects were carefully selected. Capital investment totaled ¥5.258 billion, down 51.04% from the previous fiscal year. - FY2018-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥7.758 billion during the cumulative third-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative third-quarter period.」
The Group disclosed cumulative R&D spending of ¥7.758 billion while stating that there were no material changes in the status of its activities. - FY2018-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥5.042 billion during the cumulative second-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative second-quarter period.」
The Group allocated ¥5.042 billion to R&D activities and reaffirmed its policy of continuing them, stating that there were no material changes in their status. - FY2018-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥2.397 billion during the cumulative first-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative first-quarter period.」
The Group disclosed R&D spending of ¥2.397 billion for the quarter while continuing its R&D activities and stating that there were no material changes in the status of the activities. - FY2017SoftenedAnnual report
「Capital investment declined during the fiscal year as each segment carefully selected investment projects in pursuit of investment efficiency.」
The policy of focusing capital investment on growth businesses and R&D areas was maintained, but projects were carefully selected with an emphasis on investment efficiency. Capital investment totaled ¥10.740 billion, down 18.78% from the previous fiscal year. - FY2017-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥7.218 billion during the cumulative third-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative third-quarter period.」
The Group disclosed R&D spending of ¥7.218 billion for the cumulative third-quarter period while continuing its R&D activities. - FY2017-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥5.070 billion during the cumulative second-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative second-quarter period.」
The Group disclosed cumulative R&D spending of ¥5.070 billion while stating that there were no material changes in the status of its activities. - FY2017-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥2.348 billion during the cumulative first-quarter period. There were no material changes in the status of the Group's R&D activities during the cumulative first-quarter period.」
R&D activities continued, with the amount for the quarter disclosed as ¥2.348 billion, while no material changes in the status of the activities were reported. - FY2016First statedAnnual report
「The Group invested ¥13.224 billion in capital expenditures, focusing mainly on the light-source and equipment businesses, to expand existing facilities and support businesses and R&D areas expected to grow in the future.」
The focus areas for capital investment and the investment amount for the fiscal year are stated.